Results 231 to 240 of about 267,471 (248)

The Prevalence of Allergic Rhinitis toAmbrosia Elatior in OlteniaArea and the Association with Allergic Conjunctivitis or Asthma

Current Health Sciences Journal, 2019
Introduction-Ambrosia elatior pollen sensitivity can lead to respiratory diseases such as rhinitis, asthma and allergic conjunctivitis. Ambrosia is quite an important source of pollen and it is thought to be an invasive plant.
NA FLORINCESCU-GHEORGHE, F. Popescu, D. Alexandru, F. Popescu   +3 more
semanticscholar   +1 more source

Oral Immunotherapy for Allergic Conjunctivitis

Cornea, 2014
Antigen-specific immunotherapy is expected to be a desirable treatment for allergic diseases. Currently, antigen-specific immunotherapy is performed by administering disease-causing antigens subcutaneously or sublingually. These approaches induce long-term remission in patients with allergic rhinitis or asthma.
Waka Ishida, Ken Fukuda, Hideo Yagita, Yosuke Harada, Atsuki Fukushima   +4 more
openaire   +3 more sources

An algorithm for the management of allergic conjunctivitis

Allergy and Asthma Proceedings, 2013
Allergic conjunctivitis has been reported to be increasing in prevalence in the United States. It significantly impacts patient quality of life and reduces their productivity. It has been noted that nasal and ocular symptoms are equally bothersome in the majority of patients.
Randall K. Thomas, Jimmy D. Bartlett, Kelly K. Nichols, Leonard Bielory, Eli O. Meltzer, Ron Melton   +5 more
openaire   +3 more sources

Lodoxamide Treatment of Allergic Conjunctivitis

International Archives of Allergy and Immunology, 1994
Lodoxamide is an antiallergic compound. The present study evaluated the efficacy on clinical and cytological parameters and safety of topical lodoxamide compared to placebo in the treatment of allergic conjunctivitis. The trial, designed as double-blind, randomized, placebo-controlled and parallel group treatment, was carried out in 30 patients ...
Mariangela Tosca, Giorgio Ciprandi, S. Buscaglia, P. Cerqueti, V. Ricca   +4 more
openaire   +3 more sources

Advances in pharmacotherapy for allergic conjunctivitis

Expert Opinion on Pharmacotherapy, 2015
Allergy is the fifth leading group of chronic diseases, affecting as much as 40% of the first-world population. Its pathophysiology has a genetic component, and is driven by the immune system's sensitized response to antigens and environmental factors.
Michael Korchak, Salim I. Butrus, Mark B. Abelson, Lisa M. Smith, Sirikishan Shetty   +4 more
openaire   +3 more sources

Human medicines European public assessment report (EPAR): Emadine, emedastine, Conjunctivitis, Allergic, Date of authorisation: 26/01/1999, Revision: 23, Status: Authorised

Case Medical Research, 2018

semanticscholar   +1 more source

Hydrocortisone in treatment of allergic conjunctivitis, allergic rhinitis, and bronchial asthma.

The Lancet, 1955
W. Foulds, D. Greaves, H. HERX-HEIMER, L. Kingdom   +3 more
semanticscholar   +1 more source

Treatment of Allergic Rhinitis and Allergic Conjunctivitis

The Medical Letter on Drugs and Therapeutics
Initial treatment of allergic rhinitis (AR) depends on the severity of symptoms and whether they are intermittent or persistent. Allergic conjunctivitis occurs in most patients with AR. Ocular symptoms such as itching, redness, tearing, and photophobia are frequently seasonal.
openaire   +2 more sources

Allergic Conjunctivitis

1999
BONINI, Sergio, LAMBIASE A, JUHAS T, BONINI S.   +3 more
openaire   +4 more sources

ALLERGIC CONJUNCTIVITIS

International Ophthalmology Clinics, 1988
openaire   +2 more sources